Home › Mental Disorders › Massachusetts
Mental Disorders clinical trials in Massachusetts
9 studies for Mental Disorders are looking for participants at sites in Massachusetts.
Cities in Massachusetts
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Boston
- Clinical Site, Watertown
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07459647GLP-1R Agonist Treatment for Opioid Use Disorder
- Stanley Street Treatment and Resources, Fall River
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 28, 2026 · NCT06548490A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- Massachusetts General Hospital (MGH), Charlestown
RecruitingPhase 1
Ages 50 to 85 · All sexes · Updated Aug 24, 2026 · NCT06297590Honest, Open, Proud (HOP): A Peer Delivered, Co-occurring Disorders Intervention for Justice-involved Veterans
- VA Bedford HealthCare System, Bedford, MA, Bedford
Recruiting
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT07742722Supporting Treatment Access and Recovery in COD
- Behavioral Health Network, Holyoke
- Behavioral Health Network, Orange
- Behavioral Health Network, Springfield
- and 2 more
Recruiting
Ages 18 and older · All sexes · Updated Jun 4, 2026 · NCT05138614Improving Mental Health Treatment for Individuals in Crisis Interacting With the Criminal-Legal System
- Cambridge Health Alliance, Cambridge
Recruiting
Ages 18 to 100 · All sexes · Updated Jun 4, 2026 · NCT06564948Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use
- Massachusetts General Hospital, Boston
Recruiting
Ages 18 and older · All sexes · Updated Jun 2, 2026 · NCT06878859A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Elixia MA, Springfield
- Adams Clinical, Watertown
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated May 11, 2026 · NCT06524830Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
- McLean Hospital, Belmont
RecruitingObservational study
Ages 18 to 89 · All sexes · Updated Nov 6, 2025 · NCT05245903From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.